This study highlights the non-canonical function of IDH1 in affecting epigenetic-inflammatory (PRMT1-PTX3) landscape in glioma to subsequently determine responsiveness to chemotherapeutics. This evidence concerns the gene PTX3 and central nervous system cancer.